These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24023739)

  • 1. Epigenetic regulation of pluripotent genes mediates stem cell features in human hepatocellular carcinoma and cancer cell lines.
    Wang XQ; Ng RK; Ming X; Zhang W; Chen L; Chu AC; Pang R; Lo CM; Tsao SW; Liu X; Poon RT; Fan ST
    PLoS One; 2013; 8(9):e72435. PubMed ID: 24023739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes.
    Farthing CR; Ficz G; Ng RK; Chan CF; Andrews S; Dean W; Hemberger M; Reik W
    PLoS Genet; 2008 Jun; 4(6):e1000116. PubMed ID: 18584034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract.
    Freberg CT; Dahl JA; Timoskainen S; Collas P
    Mol Biol Cell; 2007 May; 18(5):1543-53. PubMed ID: 17314394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
    Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
    Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse epigenetic profile of novel human embryonic stem cell lines.
    Lagarkova MA; Volchkov PY; Lyakisheva AV; Philonenko ES; Kiselev SL
    Cell Cycle; 2006 Feb; 5(4):416-20. PubMed ID: 16479162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells.
    Mathews LA; Hurt EM; Zhang X; Farrar WL
    Mol Cancer; 2010 Oct; 9():267. PubMed ID: 20929579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression.
    You JS; Kang JK; Seo DW; Park JH; Park JW; Lee JC; Jeon YJ; Cho EJ; Han JW
    Cancer Res; 2009 Jul; 69(14):5716-25. PubMed ID: 19567677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
    Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
    EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells.
    Chan KK; Zhang J; Chia NY; Chan YS; Sim HS; Tan KS; Oh SK; Ng HH; Choo AB
    Stem Cells; 2009 Sep; 27(9):2114-25. PubMed ID: 19522013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2.
    Doege CA; Inoue K; Yamashita T; Rhee DB; Travis S; Fujita R; Guarnieri P; Bhagat G; Vanti WB; Shih A; Levine RL; Nik S; Chen EI; Abeliovich A
    Nature; 2012 Aug; 488(7413):652-5. PubMed ID: 22902501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-type dependent regulation of pluripotency and chromatin remodeling genes by hydralazine.
    Aguirre-Vázquez A; Castorena-Torres F; Silva-Ramírez B; Peñuelas-Urquides K; Camacho-Moll ME; Salazar-Olivo LA; Velasco I; Bermúdez de León M
    Stem Cell Res Ther; 2023 Mar; 14(1):42. PubMed ID: 36927767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatin states of core pluripotency-associated genes in pluripotent, multipotent and differentiated cells.
    Barrand S; Collas P
    Biochem Biophys Res Commun; 2010 Jan; 391(1):762-7. PubMed ID: 19944068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of pluripotency inducer genes NANOG and SOX2 in human prostate cancer.
    Niharika ; Roy A; Mishra J; Chakraborty S; Singh SP; Patra SK
    Prog Mol Biol Transl Sci; 2023; 197():241-260. PubMed ID: 37019595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional reprogramming and chromatin remodeling accompanies Oct4 and Nanog silencing in mouse trophoblast lineage.
    Carey TS; Choi I; Wilson CA; Floer M; Knott JG
    Stem Cells Dev; 2014 Feb; 23(3):219-29. PubMed ID: 24059348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CARM1 is required in embryonic stem cells to maintain pluripotency and resist differentiation.
    Wu Q; Bruce AW; Jedrusik A; Ellis PD; Andrews RM; Langford CF; Glover DM; Zernicka-Goetz M
    Stem Cells; 2009 Nov; 27(11):2637-2645. PubMed ID: 19544422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression.
    Chang TS; Wu YC; Chi CC; Su WC; Chang PJ; Lee KF; Tung TH; Wang J; Liu JJ; Tung SY; Kuo LM; Ho HN; Ling TY; Huang YH
    Clin Cancer Res; 2015 Jan; 21(1):201-10. PubMed ID: 25564572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic expression and DNA methylation profiles of promoters at the parental Oct4 and Nanog genes in Mus musculus ES cell/Mus caroli splenocyte hybrid cells.
    Battulin NR; Pristyazhnyuk IE; Matveeva NM; Fishman VS; Vasilkova AA; Serov OL
    Cell Tissue Res; 2009 Sep; 337(3):439-48. PubMed ID: 19609564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of ground-state pluripotency by allelic regulation of Nanog.
    Miyanari Y; Torres-Padilla ME
    Nature; 2012 Feb; 483(7390):470-3. PubMed ID: 22327294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.